Description

This curriculum spans the full lifecycle of an epigenetics bioinformatics project, equivalent in scope to a multi-phase research program integrating study design, multi-omics data analysis, and governance, as conducted in academic medical centers or biopharma discovery teams.

Module 1: Study Design and Cohort Selection for Epigenetic Investigations

Determine appropriate sample size based on expected effect size of DNA methylation differences, balancing statistical power with cohort availability and sequencing costs.
Select case-control versus longitudinal cohort design based on research question, considering confounding due to temporal variation in methylation patterns.
Define inclusion criteria that account for biological confounders such as age, sex, smoking status, and batch collection timing to minimize noise in methylation signals.
Implement matching strategies (e.g., propensity score matching) to reduce bias when randomization is not feasible in observational epigenetic studies.
Decide between population-based versus disease-enriched cohorts depending on discovery versus validation objectives.
Establish protocols for sample collection, storage, and transport to preserve DNA integrity and avoid degradation-induced methylation artifacts.
Integrate clinical metadata collection standards to enable downstream adjustment for covariates in differential methylation analysis.
Assess feasibility of recruiting tissue-specific versus surrogate tissue (e.g., blood) samples based on target biological context and accessibility.

Module 2: Epigenomic Data Generation and Platform Selection

Choose between array-based (e.g., Illumina EPIC) and sequencing-based (e.g., WGBS, RRBS) platforms based on coverage requirements, budget, and desired resolution.
Evaluate trade-offs between whole-genome bisulfite sequencing depth and cost when detecting rare or low-methylated regions.
Implement bisulfite conversion quality control procedures to detect incomplete conversion and DNA degradation.
Design multiplexing strategies to minimize batch effects while maximizing throughput across sequencing runs.
Select appropriate library preparation kits based on input DNA quantity and quality, particularly for degraded or low-yield samples.
Establish run-specific controls including spike-ins and technical replicates to monitor platform performance.
Define data output formats (e.g., Bismark, BWA-meth) and integrate alignment pipelines during initial sequencing setup.
Negotiate data delivery terms with core facilities or sequencing vendors to ensure raw FASTQ access and metadata completeness.

Module 3: Raw Data Preprocessing and Quality Control

Implement adapter trimming and quality filtering using tools like Trim Galore! or fastp, adjusting parameters for bisulfite-converted reads.
Assess read quality using FastQC and custom scripts to detect biases introduced by bisulfite treatment.
Align bisulfite-converted reads using reference-aware aligners (e.g., Bismark, BS-Seeker2) with proper strand-specific settings.
Calculate alignment efficiency and identify samples with low mapping rates for potential exclusion or reprocessing.
Estimate global methylation levels per sample to detect outliers due to technical or biological anomalies.
Generate sample-to-sample distance matrices to identify batch effects or sample swaps early in the pipeline.
Integrate MultiQC reports into workflow to standardize QC summary across multiple runs and projects.
Apply contamination checks using methylation-based or SNP-informed tools to flag cross-sample contamination.

Module 4: Methylation Quantification and Data Normalization

Select genomic context for methylation summarization (CpG sites, regions, DMRs) based on biological question and data resolution.
Choose between beta and M-values for downstream analysis, considering statistical assumptions and transformation stability.
Apply normalization methods (e.g., SWAN, BMIQ, Noob) to correct technical variation across array probes or sequencing coverage.
Adjust for cell type heterogeneity using reference-based deconvolution (e.g., Houseman method) in whole blood or mixed tissue samples.
Implement functional normalization for array data when batch effects correlate with biological variables of interest.
Compare normalization outcomes using PCA to evaluate effectiveness in removing technical artifacts while preserving biological signal.
Handle missing methylation values through imputation or exclusion based on missingness patterns and analysis goals.
Generate coverage depth reports for sequencing data to identify loci with insufficient read support for reliable quantification.

Module 5: Differential Methylation and Association Analysis

Select statistical models (e.g., limma, methylKit, DSS) based on study design, sample size, and distributional assumptions of methylation data.
Incorporate covariates such as age, batch, and estimated cell proportions into linear models to reduce false positives.
Define significance thresholds using multiple testing correction (FDR, Bonferroni) appropriate for the number of tested CpG sites.
Perform region-based analysis by aggregating site-level signals into DMRs using tools like dmrcate or bumphunter.
Validate findings using permutation testing to assess robustness against distributional model violations.
Conduct sensitivity analyses by varying model specifications (e.g., inclusion/exclusion of covariates) to evaluate result stability.
Integrate interaction terms to test for effect modification (e.g., methylation-by-environment interactions).
Generate Manhattan and volcano plots with proper labeling to support interpretation and reporting of genome-wide results.

Module 6: Functional Annotation and Biological Interpretation

Map differentially methylated positions or regions to genomic features (promoters, enhancers, CpG islands) using annotation databases like IlluminaHumanMethylationEPICanno.
Perform enrichment analysis for regulatory elements using tools such as GOMeth or EnrichedHeatmap to link methylation changes to biological pathways.
Integrate chromatin state data (e.g., ENCODE, Roadmap Epigenomics) to assess overlap with active or repressed regulatory regions.
Link methylation changes to potential gene expression effects using eQTM databases or paired methylation-RNAseq datasets.
Interpret directionality of methylation changes in context of gene regulation (e.g., hypermethylation in promoters often associated with silencing).
Use gene set enrichment analysis (GSEA) to detect coordinated methylation changes across biological pathways.
Validate biological relevance by cross-referencing findings with published epigenome-wide association studies (EWAS).
Assess potential for causal inference using Mendelian randomization frameworks when genetic instruments are available.

Module 7: Integration with Multi-Omics Data

Align genomic coordinates across methylation, transcriptomic, and genetic datasets to enable cross-platform integration.
Perform co-localization analysis to identify methylation-QTLs (meQTLs) using genotype and methylation data from the same individuals.
Apply integrative clustering (e.g., iCluster, MOFA) to identify epigenetic subtypes that align with transcriptional or clinical profiles.
Model methylation as mediator in gene expression regulation using mediation analysis frameworks.
Harmonize batch effects across omics layers when data are generated in separate experiments or facilities.
Select dimensionality reduction techniques (e.g., PCA, UMAP) that preserve biological variance across multiple data types.
Validate cross-omics findings using independent datasets or orthogonal experimental assays.
Manage computational complexity when integrating high-dimensional datasets through feature selection or data summarization.

Module 8: Data Management, Reproducibility, and Governance

Design folder and file naming conventions to support traceability from raw data to final results across analysis stages.
Implement version control for analysis scripts using Git, with branching strategies for exploratory versus production code.
Containerize analysis pipelines using Docker or Singularity to ensure computational reproducibility.
Document metadata using standardized formats (e.g., ISA-Tab) to support data sharing and reuse.
Apply data encryption and access controls to protect sensitive epigenetic and phenotypic information.
Establish data retention and archiving policies in compliance with institutional and funding body requirements.
Register analysis protocols in public repositories (e.g., protocols.io) to enhance transparency.
Implement pipeline monitoring to log computational resource usage and detect failures in long-running jobs.

Module 9: Regulatory Compliance and Ethical Considerations in Epigenetic Research

Obtain IRB approval for studies involving human epigenetic data, including re-use of previously collected samples.
Assess whether methylation data are considered identifiable under GDPR or HIPAA based on potential for re-identification.
Develop data use agreements that specify permitted analyses and restrict unauthorized secondary use.
Implement tiered access systems for sensitive datasets to limit exposure to authorized personnel.
Evaluate ethical implications of detecting incidental findings (e.g., cancer-associated methylation signatures) in research settings.
Address participant consent language regarding future use of epigenetic data, especially for longitudinal or data-sharing initiatives.
Report data breaches involving epigenetic information according to institutional and legal mandates.
Engage with ethics boards early when planning studies involving vulnerable populations or stigmatized conditions.